Trial intelligence / Profile preview

Oral UT-15C in Critical Limb Ischemia and Ischemic Rest Pain

NCT00445159Phase 2Unknown

Sponsor
Southern Arizona Vascular Institute
Start
Nov 2006
Countries
1
01

Overview

A Phase 2 trial of treprostinil in critical limb ischemia (CLI), sponsored by Southern Arizona Vascular Institute. Status: unknown.

02

Drugs

treprostinil
03

Conditions

critical limb ischemia (CLI)

Beyond the preview

Go deeper on NCT00445159.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00445159.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call